These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 23433825
1. Blood group genotyping in multi-transfused patients. Bakanay SM, Ozturk A, Ileri T, Ince E, Yavasoglu S, Akar N, Uysal Z, Arslan O. Transfus Apher Sci; 2013 Apr; 48(2):257-61. PubMed ID: 23433825 [Abstract] [Full Text] [Related]
2. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Castilho L, Rios M, Bianco C, Pellegrino J, Alberto FL, Saad ST, Costa FF. Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340 [Abstract] [Full Text] [Related]
3. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice. Breiki ASA, Kindi SA, Castilho L. Immunohematology; 2024 Sep 01; 40(3):93-99. PubMed ID: 39373300 [Abstract] [Full Text] [Related]
4. Alloimmunization in sickle cell anemia in the era of extended red cell typing. O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA. Pediatr Blood Cancer; 2013 Sep 01; 60(9):1487-91. PubMed ID: 23508932 [Abstract] [Full Text] [Related]
5. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications. Fasano RM, Chou ST. Transfus Med Rev; 2016 Oct 01; 30(4):197-201. PubMed ID: 27345938 [Abstract] [Full Text] [Related]
6. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J, Castilho L. Vox Sang; 2009 Aug 01; 97(2):147-52. PubMed ID: 19392786 [Abstract] [Full Text] [Related]
7. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Rozman P, Dovc T, Gassner C. Transfusion; 2000 Aug 01; 40(8):936-42. PubMed ID: 10960520 [Abstract] [Full Text] [Related]
8. Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran. Sarihi R, Oodi A, Dadkhah Tehrani R, Jalali SF, Mardani F, Azarkeivan A, Gudarzi S, Amirizadeh N. Mol Genet Genomic Med; 2021 Jul 01; 9(7):e1701. PubMed ID: 33963817 [Abstract] [Full Text] [Related]
9. Molecular genotyping of clinically important blood group antigens in patients with thalassaemia. Kulkarni S, Choudhary B, Gogri H, Patil S, Manglani M, Sharma R, Madkaikar M. Indian J Med Res; 2018 Dec 01; 148(6):713-720. PubMed ID: 30778005 [Abstract] [Full Text] [Related]
10. Frequency of red blood cell genotypes in multi-transfused patients and blood donors from Minas Gerais, Southeast Brazil. Alves VM, De Vito FB, Martins PRJ, Silva SS, Castilho L, Moraes-Souza H. Transfus Apher Sci; 2018 Feb 01; 57(1):71-75. PubMed ID: 29330014 [Abstract] [Full Text] [Related]
11. Prospects for the provision of genotyped blood for transfusion. Denomme GA. Br J Haematol; 2013 Oct 01; 163(1):3-9. PubMed ID: 23889672 [Abstract] [Full Text] [Related]
12. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Cheng CK, Lee CK, Lin CK. Transfusion; 2012 Oct 01; 52(10):2220-4. PubMed ID: 22339270 [Abstract] [Full Text] [Related]
13. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A. Transfusion; 2013 Apr 01; 53(4):710-5. PubMed ID: 22845746 [Abstract] [Full Text] [Related]
14. Comparison of serology and molecular detection of common red cell antigens in multitransfused thalassemia major and sickle cell disease patients. Shah A, Patel P, Patel K, Patel B, Jariwala K, Sharma P, Mishra K, Ghosh K. Transfus Apher Sci; 2020 Feb 01; 59(1):102599. PubMed ID: 31326292 [Abstract] [Full Text] [Related]
15. Benefits of blood group genotyping in multi-transfused patients from the south of Brazil. Guelsin GA, Sell AM, Castilho L, Masaki VL, Melo FC, Hashimoto MN, Higa TT, Hirle LS, Visentainer JE. J Clin Lab Anal; 2010 Feb 01; 24(5):311-6. PubMed ID: 20872565 [Abstract] [Full Text] [Related]
16. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Papay P, Hackner K, Vogelsang H, Novacek G, Primas C, Reinisch W, Eser A, Mikulits A, Mayr WR, Körmöczi GF. Am J Med; 2012 Jul 01; 125(7):717.e1-8. PubMed ID: 22560809 [Abstract] [Full Text] [Related]
17. A comparison of serological phenotyping and molecular genotyping for Kell, Kidd, and Duffy antigens in multi-transfused thalassemia patients. Sonker A, Dubey A, Mohan Y. Asian J Transfus Sci; 2023 Jul 01; 17(1):53-57. PubMed ID: 37188031 [Abstract] [Full Text] [Related]
18. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Legler TJ, Eber SW, Lakomek M, Lynen R, Maas JH, Pekrun A, Repas-Humpe M, Schröter W, Köhler M. Transfusion; 1999 Aug 01; 39(8):852-5. PubMed ID: 10504121 [Abstract] [Full Text] [Related]
19. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping--the alternative approach. Gassner C, Meyer S, Frey BM, Vollmert C. Transfus Med Rev; 2013 Jan 01; 27(1):2-9. PubMed ID: 23217607 [Abstract] [Full Text] [Related]
20. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM. Transfus Med; 2020 Aug 01; 30(4):263-274. PubMed ID: 32432400 [Abstract] [Full Text] [Related] Page: [Next] [New Search]